These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

383 related items for PubMed ID: 16467658

  • 1. Microalbuminuria and tubular proteinuria as risk predictors of cardiovascular morbidity and mortality in essential hypertension: final results of a prospective long-term study (MARPLE Study)*.
    Schrader J, Lüders S, Kulschewski A, Hammersen F, Züchner C, Venneklaas U, Schrandt G, Schnieders M, Rangoonwala B, Berger J, Dominiak P, Zidek W, MARPLE Study Group.
    J Hypertens; 2006 Mar; 24(3):541-8. PubMed ID: 16467658
    [Abstract] [Full Text] [Related]

  • 2. The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure: a prospective, randomized, controlled prevention trial of the German Hypertension League.
    Lüders S, Schrader J, Berger J, Unger T, Zidek W, Böhm M, Middeke M, Motz W, Lübcke C, Gansz A, Brokamp L, Schmieder RE, Trenkwalder P, Haller H, Dominiak P, PHARAO Study Group.
    J Hypertens; 2008 Jul; 26(7):1487-96. PubMed ID: 18551027
    [Abstract] [Full Text] [Related]

  • 3. Effect of lercanidipine compared with ramipril on albumin excretion rate in hypertensive Type 2 diabetic patients with microalbuminuria: DIAL study (diabete, ipertensione, albuminuria, lercanidipina).
    Dalla Vestra M, Pozza G, Mosca A, Grazioli V, Lapolla A, Fioretto P, Crepaldi G.
    Diabetes Nutr Metab; 2004 Oct; 17(5):259-66. PubMed ID: 16295047
    [Abstract] [Full Text] [Related]

  • 4. Assessment of patients' and physicians' compliance to an ACE inhibitor treatment based on urinary N-acetyl Ser-Asp-Lys-Pro determination in the Noninsulin-Dependent Diabetes, Hypertension, Microalbuminuria, Proteinuria, Cardiovascular Events, and Ramipril (DIABHYCAR) study.
    Azizi M, Ménard J, Peyrard S, Lièvre M, Marre M, Chatellier G.
    Diabetes Care; 2006 Jun; 29(6):1331-6. PubMed ID: 16732017
    [Abstract] [Full Text] [Related]

  • 5. Safety and tolerability of ramipril 10 mg in patients at high risk of cardiovascular events: an observational study.
    Hathial M.
    Indian Heart J; 2008 Jun; 60(3):200-4. PubMed ID: 19240307
    [Abstract] [Full Text] [Related]

  • 6. Microalbuminuria and hypertension.
    Reboldi G, Gentile G, Angeli F, Verdecchia P.
    Minerva Med; 2005 Aug; 96(4):261-75. PubMed ID: 16179893
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The HOPE Study (Heart Outcomes Prevention Evaluation).
    Sleight P.
    J Renin Angiotensin Aldosterone Syst; 2000 Mar; 1(1):18-20. PubMed ID: 11967789
    [Abstract] [Full Text] [Related]

  • 9. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD, Mion D, Rocha JC, Kohlmann O, Gomes MA, Saraiva JF, Amodeo C, Filho BL.
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [Abstract] [Full Text] [Related]

  • 10. Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease.
    Zeltner R, Poliak R, Stiasny B, Schmieder RE, Schulze BD.
    Nephrol Dial Transplant; 2008 Feb; 23(2):573-9. PubMed ID: 17984104
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Evaluation of efficacy and tolerability of Losartan and Ramipril combination in the management of hypertensive patients with associated diabetes mellitus in India (LORD Trial).
    Joshi SR, Yeolekar ME, Tripathi KK, Giri J, Maity AK, Chopda M, Gujarathi S, Maroli S, Maity A, LORD Trial.
    J Assoc Physicians India; 2004 Mar; 52():189-95. PubMed ID: 15636307
    [Abstract] [Full Text] [Related]

  • 13. Association of heart rate with microalbuminuria in cardiovascular risk patients: data from I-SEARCH.
    Böhm M, Reil JC, Danchin N, Thoenes M, Bramlage P, Volpe M.
    J Hypertens; 2008 Jan; 26(1):18-25. PubMed ID: 18090536
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Hypertension, heart failure, myocardial infarction, secondary prevention: the role of perindopril].
    Rapezzi C, Ciliberti P, Graziosi M, Riva L.
    Ital Heart J; 2005 Nov; 6 Suppl 7():40S-47S. PubMed ID: 16485516
    [Abstract] [Full Text] [Related]

  • 16. [Stress-associated hypertension in the work place: results of the STARLET project].
    Lüders S, Hammersen F, Kulschewski A, Frerichs A, Frieg R, Hahnheiser D, Reich G, Schnieders M, Schrandt G, Schrader J.
    Dtsch Med Wochenschr; 2006 Nov 17; 131(46):2580-5. PubMed ID: 17096303
    [Abstract] [Full Text] [Related]

  • 17. The smoothness of blood pressure control of ramipril in essential hypertensive Thai patients evaluation by 24-hour ambulatory blood pressure monitoring.
    Uchaipichat V, Koanantakul B, Suthisisang C.
    J Med Assoc Thai; 2008 Sep 17; 91(9):1468-77. PubMed ID: 18843880
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Prediction, screening and treatment of renal complications of diabetes].
    Marre M, Larger E.
    Rev Prat; 2001 Oct 15; 51(16):1769-75. PubMed ID: 11795120
    [Abstract] [Full Text] [Related]

  • 20. Effect of antihypertensive treatment on qualitative estimates of microalbuminuria.
    Agrawal B, Wolf K, Berger A, Luft FC.
    J Hum Hypertens; 1996 Aug 15; 10(8):551-5. PubMed ID: 8895040
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.